Hims & Hers Health (HIMS) revenue and earnings history
Hims & Hers Health reported revenue of $2.35B for fiscal 2025 (year ended Dec 31, 2025), +59.0% on the year before, and net income of $128M.
Over 6 years, from fiscal 2019 to fiscal 2025, revenue grew at a compound rate of +74.7% a year.
Revenue and net income, 7 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.35B+59.0% | $106M | $128M | $300M | $243M | $57.4M | $135M | $90M | — | $229M | — | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Hims & Hers Health (HIMS) on OQRO.
Common questions
What was Hims & Hers Health's revenue in fiscal 2025?
$2.35B for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 23, 2026. That is +59.0% on fiscal 2024 ($1.48B).
How fast has Hims & Hers Health's revenue grown?
From $82.6M in fiscal 2019 to $2.35B in fiscal 2025: a compound annual growth rate of +74.7% over 6 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Hims & Hers Health tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
